The Effects of GLP-1 on Fat Distribution: Uncovering the Truth
Introduction
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have been gaining significant attention in the medical community due to their potential in treating type 2 diabetes, obesity, and metabolic diseases. One of the lesser-known but crucial aspects of GLP-1RAs is their effect on fat distribution. In this article, we will delve into the effects of GLP-1 on fat distribution, exploring the mechanisms behind this phenomenon and the implications for individuals with diabetes, obesity, and non-alcoholic fatty liver disease (NAFLD).What are GLP-1RAs and how do they work?
